Key Drivers
- Strong gross margins
- Positive free cashflow
- High valuation premium
AIAI Summary
CWAN is fundamentally a high‑margin, cash‑generative SaaS whose investment case has shifted from pure growth upside to a deal‑and‑execution play—so prioritize monitoring integration milestones (Enfusion/Beacon/Bistro), net‑debt/EBITDA trajectory, and the $24.55 buyout litigation timeline because those three outcomes will determine whether the current market valuation is justified or vulnerable to a sharp rerating.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong gross margins
- •Positive free cashflow
- •High valuation premium
CWAN delivers strong gross margins and free cash flow but generates accounting net losses amid heavy R&D/opex and an intangible‑heavy balance sheet while trading at a very high EV/EBITDA multiple.
Price Behavior
Key Price Behavior Insights:
- •Tight range
- •Muted momentum
- •Near support/resistance
CWAN is trading in a tight, low-volatility range just above its last month SMA (~$23.36), with neutral momentum (RSI ~47) and immediate support near $23.14 versus resistance around $23.50–$23.54.
Narrow band trading last month indicates unusually low short-term volatility
Sentiment & News
Key News Insights:
- •Legal probes
- •Activist stake
- •Derivative activity
Multiple law-firm probes, activist repositioning and unusual insider/derivative activity have intensified scrutiny of Clearwater's $24.55 buyout while the firm continues commercial wins like Orange Investment Advisors adopting its Enfusion platform.
Heightened litigation risk and investor repositioning could pressure deal terms and share price near-term, even as commercial traction supports long-term valuation
Similar Companies in Technology
Other companies in the same sector with AI ratings